PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: AnaSpec, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

AnaSpec Introduces Improved MMP Detection Solutions - Current EnzoLyte™ MMP assay kits can sensitively detect the activity of MMPs but have been limited in their specificity by the cross-reactions between different MMPs.
AnaSpec Introduces Improved MMP Detection Solutions

 

NewswireToday - /newswire/ - San Jose, CA, United States, 2006/11/02 - Current EnzoLyte™ MMP assay kits can sensitively detect the activity of MMPs but have been limited in their specificity by the cross-reactions between different MMPs..

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

With the introduction of EnzoLyte PlusTM MMP assay kits, AnaSpec presents an optimized solution for the identification of specific MMPs. Matrix Metalloproteinases (MMPs) belong to a family of secreted or membrane-associated zinc endopeptidases capable of digesting extracellular matrix components (1,2). These enzymes are responsible for connective tissue deterioration, bone remodeling, and damaged tissue repair. They are also involved in a number of diseases, such as tumor development and metastasis (3-6) as well as in rheumatoid arthritis (7,8).

EnzoLyte Plus™ MMP assay kits provide an innovative solution for researchers who need to identify the activity of a specific MMP in a complex biological sample containing multiple MMPs and other peptidases. EnzoLyte Plus™ MMP Assay Kits integrate the specificity of a monoclonal antibody with the sensitivity of a fluorescence peptide substrate, detecting the presence of a particular MMP in biological samples, including serum, plasma, tissue homogenate, cell lysate, and synovial fluid.

The enhanced selectivity is possible through the inclusion of a monoclonal anti human-MMP coated 96-well plate (12 x 8 black strips). The antibody specifically captures the proenzyme and active forms of an MMP from a mixed biological sample. The wells are washed and subsequent addition and cleavage of the FRET peptide gives a fluorimetric reading that reflects the proteolytic activity of the specifically captured MMP. AnaSpec’s unique 5-FAM/QXLTM 520 FRET peptides provide highly sensitive fluorescence readouts at an emission wavelength of 520 nm with a convenient excitation of 490 nm. Experimental data confirms that these kits can measure subnanogram quantities of specific human MMPs, with no cross-reaction to other MMPs.

AnaSpec currently offers the following MMP-specific assay kits:

• EnzoLyte Plus™ 520 MMP-1 Assay Kit
• EnzoLyte Plus™ 520 MMP-9 Assay Kit
• EnzoLyte Plus™ 520 MMP-13 Assay Kit

References

1. Woessner, JF. Jr. and CJ. Taplin, J. Biol. Chem. 263, 16918 (1988).
2. Woessner, JF. Jr., FASEB J. 5, 2145 (1991).
3. Matrisian, LM. et al., Proc. Natl. Acad. Sci. U.S.A 83, 9413 (1986).
4. Collier, IE. et al., J. Biol. Chem. 263, 6579 (1988).
5. Salo, T. et al. J. Biol. Chem. 258, 3058 (1983).
6. Salo, T. et al. J. Biol. Chem. 260, 8526 (1985).
7. Chin, JR.et al. J. Biol. Chem. 260, 12367 (1985).
8. Okada, Y.et al. J. Biol. Chem. 261, 14245 (1986).

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: AnaSpec, Inc.

 
 

Availability: All Metropolitan Area

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


AnaSpec Introduces Improved MMP Detection Solutions

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Debra Thai 
408-452-5055 marketing[.]anaspec.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AnaSpec, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From AnaSpec, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)